<DOC>
	<DOCNO>NCT00152269</DOCNO>
	<brief_summary>The objective study determine safety effectiveness asoprisnil symptomatic woman abnormal uterine bleeding associate uterine fibroid .</brief_summary>
	<brief_title>Treatment Uterine Fibroids With Asoprisnil ( J867 )</brief_title>
	<detailed_description>No medical therapy currently available long-term treatment abnormal uterine bleeding associate uterine fibroid woman many woman must resort surgery relief . The objective study determine safety efficacy asoprisnil 10 mg 25 mg tablet , compare placebo , administer daily 12 month woman abnormal uterine bleeding associate uterine fibroid , assess whether asoprisnil administration prevents surgical and/or invasive intervention study population . Women , meet predefined uterine bleeding criterion surgical and/or invasive intervention ( hysterectomy , myomectomy , uterine artery embolization ) willing undergo surgical and/or invasive intervention study medication fails , enrol study .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<criteria>Premenopausal woman History regular menstrual cycle ( 2142 day ) Diagnosis uterine fibroid ( ) Abnormal vaginal bleeding associate uterine fibroid Otherwise good health Agrees undergo surgery ( hysterectomy ) invasive procedure study medication fail Negative pregnancy test Agrees Doublebarrier method contraception Pap smear evidence malignancy premalignant change Endometrial biopsy significant histological disorder Any abnormal lab procedure result studydoctor considers important Severe reaction ( ) currently use hormone therapy History osteoporosis bone disease Previous myomectomy 1 year and/or previous uterine artery embolization within 6 month History Polycystic Ovary Syndrome prolactinoma MRI show significant gynecologic disorder Uterine size &gt; 25 week gestation Hemoglobin &lt; 8 g/dL Day 1</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Symptomatic Uterine Fibroids</keyword>
	<keyword>Excessive Uterine Bleeding</keyword>
	<keyword>Uterine Hemorrhage</keyword>
	<keyword>asoprisnil</keyword>
</DOC>